These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 944392

  • 1. Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease.
    Barbeau A, Roy M.
    Neurology; 1976 May; 26(5):399-404. PubMed ID: 944392
    [Abstract] [Full Text] [Related]

  • 2. Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.
    Rinne UK, Birket-Smith E, Dupont E, Hansen E, Hyyppä M, Marttila R, Mikkelsen B, Pakkenberg H, Presthus J.
    J Neurol; 1975 Dec 02; 211(1):1-9. PubMed ID: 56427
    [Abstract] [Full Text] [Related]

  • 3. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
    Lieberman A, Goodgold A, Jonas S, Leibowitz M.
    Neurology; 1975 Oct 02; 25(10):911-6. PubMed ID: 1101099
    [Abstract] [Full Text] [Related]

  • 4. Open study of Madopar HBS, a new formulation of levodopa with benserazide, in 13 patients with Parkinson's disease and 'on-off' fluctuations.
    Quinn NP, Marion MH, Marsden CD.
    Eur Neurol; 1987 Oct 02; 27 Suppl 1():105-13. PubMed ID: 3322834
    [Abstract] [Full Text] [Related]

  • 5. Levodopa with benserazide or carbidopa in Parkinson disease.
    Rinne UK, Mölsä P.
    Neurology; 1979 Dec 02; 29(12):1584-9. PubMed ID: 574221
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Report on 45-month treatment of parkinsonism with L-dopa, alone and in association with a decarboxilase inhibitor (Ro 4-4602).
    Chouza C, Romero S, Gomensoro JB.
    Acta Neurol Latinoam; 1974 Dec 02; 20(1-4):116-38. PubMed ID: 4619960
    [No Abstract] [Full Text] [Related]

  • 9. [Levodopa and decarboxylase inhibitors in Parkinson's disease].
    Gilland O.
    Lakartidningen; 1977 Jan 05; 74(1-2):37-40. PubMed ID: 318722
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial.
    Pakkenberg H, Birket-Smith E, Dupont E, Hansen E, Mikkelsen B, Presthus J, Rautakorpi I, Riman E, Rinne UK.
    Acta Neurol Scand; 1976 May 05; 53(5):376-85. PubMed ID: 1266576
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
    Mondal BK, Mondal KN.
    Pharmatherapeutica; 1986 May 05; 4(9):571-6. PubMed ID: 3094036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
    Podiwinsky F, Mentasti M, Riederer P, Birkmayer W.
    Wien Klin Wochenschr; 1979 May 11; 91(10):332-7. PubMed ID: 452602
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Madopar HBS: slow-release levodopa and benserazide in parkinsonian patients presenting marked fluctuations in symptoms on standard L-dopa treatment.
    Jensen NO, Dupont E, Hansen E, Mikkelsen B, Mikkelsen BO.
    Eur Neurol; 1987 May 11; 27 Suppl 1():68-72. PubMed ID: 3428310
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.